Janssen Pharmaceutica N.V. Announces Collaboration To Develop Diagnostic Biosignatures For Pre-Symptomatic Identification Of Alzheimer's Disease
BEERSE, Belgium, December 1, 2010 /PRNewswire/ -- Janssen Pharmaceutica N.V., (Janssen) today announced a research agreement to collaborate with GE Healthcare to develop non-invasive or minimally…